Selected Grants
GeoSentinel Network
ResearchPrincipal Investigator · Awarded by International Society of Travel Medicine · 2025 - 2035CIVICS Component C - Option 8B.2 Phase 1
ResearchInvestigator · Awarded by National Institutes of Health · 2026 - 2028Phase 1, Open-Label, Safety, Reactogenicity, and Immunogenicity Trial of RVX-sCPD9, a live-attenuated SARS-CoV-2 virus, as a Booster Vaccine, Via the Intranasal Route, in Previously Vaccinated Adults
ResearchInvestigator · Awarded by Leidos Biomedical Research, Inc. · 2026 - 2027A randomized controlled trial of a novel, evidence-based algorithm for managing lower respiratory tract infection in a resource-limited setting
ResearchInvestigator · Awarded by National Institute of Allergy and Infectious Diseases · 2022 - 2027Phase 1: A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes
ResearchInvestigator · Awarded by Leidos Biomedical Research, Inc. · 2026 - 2026External Relationships
- Bavarian-Nordic
- Oxon Epidemiology
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.